(Reuters) -Guardian Pharmacy's shares rise 3.3% in their NYSE debut, giving the healthcare firm a market valuation of about $880 million, as investors remain selective about new listings.

Shares of the Atlanta, Georgia-based firm debuted at $14.46 apiece compared to their IPO price of $14.

The company on Wednesday had raised $112 million by selling 8 million shares of Class A common stock at the low-end of its targeted range of $14 to $16 each.

The U.S. capital markets have recovered strongly after two dismal years of IPO activity, on the back of expectations of Quantitative Easing will help restore investor appetite for new entrants.

However, investors have been cautious about new listings even as technology has been the dominant sector for new issues in the U.S.